{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Thalidomide, the drug whose use in the 1960's produced thousands of babies with flipperlike arms and other gross deformities, is on the verge of receiving approval from the Food and Drug Administration, nearly four decades after the agency's legendary decision to reject it for use in the United States. Officials at the agency announced today that they intended to approve thalidomide for use in leprosy patients, as long as the New Jersey-based company seeking to market it could adhere to several conditions, including elaborate restrictions intended to keep the drug away from women who are or might become pregnant.", "headline": {"main": "37 YEARS LATER, A SECOND CHANCE FOR THALIDOMIDE"}, "abstract": "Thalidomide, drug which caused widespread birth defects in 1960's and was rejected for use in US, is on verge of Federal approval for treatment of leprosy, nearly four decades after it was banned; officials say they will approve use as long as manufacturer, Celgene Corp, adheres to several conditions, including elaborate restrictions intended to keep it away from women who are or might become pregnant; drug has been experiencing revival of sorts in recent years, and scientists are experimenting with it for treatment of variety of ailments; company spokesman Dr Murray Lumpkin comments (M)", "print_page": "1", "word_count": 1371, "_id": "4fd1d7f18eb7c8105d7163c0", "snippet": "Thalidomide, the drug whose use in the 1960's produced thousands of babies with flipperlike arms and other gross deformities, is on the verge of receiving approval from the Food and Drug Administration, nearly four decades after the agency's...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/09/23/us/37-years-later-a-second-chance-for-thalidomide.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "LUMPKIN, MURRAY"}, {"name": "organizations", "value": "CELGENE CORP"}, {"name": "subject", "value": "BIRTH DEFECTS"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "THALIDOMIDE (DRUG)"}, {"name": "subject", "value": "LEPROSY (HANSEN'S DISEASE)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}], "byline": {"person": [{"firstname": "Sheryl", "middlename": "Gay", "lastname": "STOLBERG", "rank": 1, "role": "reported", "organization": ""}], "original": "By SHERYL GAY STOLBERG"}, "document_type": "article", "pub_date": "1997-09-23T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 1, "offset": 0, "time": 31}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}